Analysis of loss of heterozygosity in lymphoma and leukaemia arising in F1 hybrid mice locates a common region of chromosome 4 loss
β Scribed by Emmy Meijne; Rene Huiskamp; Jackie Haines; John Moody; Rosemary Finnon; Jennifer Wilding; Sylvia Spanjer; Simon Bouffler; Alan Edwards; Roger Cox; Andrew Silver
- Book ID
- 102219246
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 132 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1045-2257
- DOI
- 10.1002/gcc.1156
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Previous studies have identified five lymphomaβrelated tumour suppressor gene regions on murine chromosome 4. Using detailed allelotype analysis on a range of lymphoβhaematopoietic tumour types arising in F1 hybrid mice, we now show a consistent pattern of loss of heterozygosity (LOH) which identifies a common region of loss delineated by microsatellites D4Mit21 and D4Mit53 on proximal chromosome 4. This critical segment corresponds to the thymic lymphoma tumour suppressor region 5 (TLSR5) identified in an earlier study. Tumours of this type have also been reported as showing allelic loss from the Trp53 and Ikaros regions on chromosome 11. In the present study, only a small fraction of tumours showed LOH in the Ikaros region, while a minority of lymphomas, but not acute myeloid leukaemias, showed allelic loss of the chromosome 11 segment encoding Trp53. These and other data indicate strongly that the genomic regions identified as showing recurrent LOH depend on the genetic background of the mice. Overall, the results indicate a key role for a tumour suppressor gene(s) encoded in an βΌ3 cM segment on proximal chromosome 4 and provide an experimental basis for the further investigation of the functional role of candidate genes which include Pax5 and Tgfbr1. Β© 2001 WileyβLiss, Inc.
π SIMILAR VOLUMES
B6D2F 1 mice (45/group) were treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) or uracil as follows: Group 1 received 0.05% BBN in drinking water for the entire experiment, Group 2 received 5 mg of BBN by gastric gavage in 0.1 mL of 20% ethanol twice per week for 10 wk, Group 3 received a 2.5